BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2392142)

  • 1. Treating drug problems.
    Gerstein DR; Lewin LS
    N Engl J Med; 1990 Sep; 323(12):844-8. PubMed ID: 2392142
    [No Abstract]   [Full Text] [Related]  

  • 2. A structured, therapeutic approach to drug abuse.
    Alonzi J; Faigel HC
    Pediatrics; 1972 Nov; 50(5):754-9. PubMed ID: 5084188
    [No Abstract]   [Full Text] [Related]  

  • 3. A differential counselor role model for the treatment of drug addicts.
    Cuskey WR; Premkumar T
    Health Serv Rep; 1973; 88(7):663-8. PubMed ID: 4746235
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug abuse programs: are hospitals too late and too square?
    Philips DF
    Hospitals; 1971 Jan; 45(2):55-60. PubMed ID: 5123315
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment facilities for drug-dependent patients. Some impressions of treatment programmes in the United States and Canada.
    Jensen GR
    Med J Aust; 1973 Apr; 1(16):808-12. PubMed ID: 4707801
    [No Abstract]   [Full Text] [Related]  

  • 6. The quality of treatment for drug abuse.
    Glaser FB; Adler F; Moffett AD; Ball JC
    Am J Psychiatry; 1974 May; 131(5):598-601. PubMed ID: 4819055
    [No Abstract]   [Full Text] [Related]  

  • 7. The effectiveness of drug treatment.
    Gerstein DR
    Res Publ Assoc Res Nerv Ment Dis; 1992; 70():253-82. PubMed ID: 1311121
    [No Abstract]   [Full Text] [Related]  

  • 8. Forecasting the cost of drug abuse treatment coverage in private health insurance.
    McGuire TG; Shatkin BF
    NIDA Res Monogr; 1991; 113():175-89. PubMed ID: 1762639
    [No Abstract]   [Full Text] [Related]  

  • 9. What's happening in hard-drug rehabilitation?
    Walls RT; Gulkus SP
    Rehabil Lit; 1973 Jan; 34(1):2-6. PubMed ID: 4683507
    [No Abstract]   [Full Text] [Related]  

  • 10. The costs of pursuing accreditation for methadone treatment sites: results from a national study.
    Zarkin GA; Dunlap LJ; Homsi G
    Eval Rev; 2006 Apr; 30(2):119-38. PubMed ID: 16492995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treating the drug-dependent veteran.
    Van Stone W; Zarcone V; Bale R; Engelsing T
    Curr Psychiatr Ther; 1976; 16():215-22. PubMed ID: 991633
    [No Abstract]   [Full Text] [Related]  

  • 12. A cost-effectiveness model for evaluating health care programs: application to drug abuse treatment.
    Goldschmidt PG
    Inquiry; 1976 Mar; 13(1):29-47. PubMed ID: 130347
    [No Abstract]   [Full Text] [Related]  

  • 13. A profile of the substance abuse treatment industry: organization, costs, and treatment completion.
    Woodward AM; Raskin IE; Blacklow B
    Subst Use Misuse; 2008; 43(5):647-79. PubMed ID: 18393082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study tracks costs of treating employees' drug problems.
    Kim H
    Mod Healthc; 1991 Jan; 21(3):18. PubMed ID: 10170655
    [No Abstract]   [Full Text] [Related]  

  • 15. [When and how one can leave a methadone treatment program?].
    Lauzon P
    Ann Med Interne (Paris); 1994 Nov; 145 Suppl 3():94-5. PubMed ID: 7880041
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study.
    Peirce JM; Petry NM; Stitzer ML; Blaine J; Kellogg S; Satterfield F; Schwartz M; Krasnansky J; Pencer E; Silva-Vazquez L; Kirby KC; Royer-Malvestuto C; Roll JM; Cohen A; Copersino ML; Kolodner K; Li R
    Arch Gen Psychiatry; 2006 Feb; 63(2):201-8. PubMed ID: 16461864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of alternative staff time data collection methods on drug treatment service cost estimates.
    Zarkin GA; Dunlap LJ; Wedehase B; Cowell AJ
    Eval Program Plann; 2008 Nov; 31(4):427-35. PubMed ID: 18640722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost containment: a challenge to physicians.
    Magee TM
    Conn Med; 1987 Jul; 51(7):485. PubMed ID: 3665473
    [No Abstract]   [Full Text] [Related]  

  • 19. The methadone method.
    Whyman JS; Woody GE; Patch VD
    N Engl J Med; 1972 Mar; 286(13):728-9. PubMed ID: 5061064
    [No Abstract]   [Full Text] [Related]  

  • 20. The costs of crime and the benefits of drug abuse treatment: a cost-benefit analysis using TOPS data.
    Harwood HJ; Hubbard RL; Collins JJ; Rachal JV
    NIDA Res Monogr; 1988; 86():209-35. PubMed ID: 3140032
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.